Nuzenio

Psma Therapy

Psma Therapy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 12:24:46 GMTFDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - Novartis
Fri, 07 Aug 2026 21:54:26 GMTPSMA PET Interpretation in Biochemical Recurrence After Prostate Cancer Treatment - Steve Cho - UroToday
Thu, 06 Aug 2026 01:09:35 GMTTLX591 Antibody-Based Lutetium-177 PSMA Therapy in Metastatic CRPC - Pedro Barata - UroToday
Wed, 05 Aug 2026 10:28:25 GMTFDA Approved Pluvicto Plus ARPI for PSMA-Positive mAPMN/S Prostate Cancer - Oncodaily
Tue, 04 Aug 2026 04:15:13 GMTWhy You Might Need a PSMA PET Scan for Advanced Prostate Cancer - Cleveland Clinic Health Essentials
Mon, 03 Aug 2026 23:11:02 GMTFDA Approves Pluvicto for Early-Stage Metastatic Prostate Cancer - WebMD

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Psma Therapy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.